Who owns Northwest Biotherapeutics In?
- Ticker: NWBO
- CUSIP Number: 66737P600
Tip: Access positions for across all investors
Analyze quarterly positions in Northwest Biotherapeutics In with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Northwest Biotherapeutics In stock
Who bought or sold Northwest Biotherapeutics In this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Moloney Securities Asset Management | 535k | $128k | 7% | Sep 2025 |
|
| VSM Wealth Advisory | 66k | $16k | 0% | Sep 2025 |
|
| Opus Capital Group | 60k | $14k | 0% | Sep 2025 |
|
| Williams Jones Wealth Management | 27k | $6.5k | 0% | Sep 2025 |
|
| Ethos Financial Group | 25k | $6.1k | -48% | Sep 2025 |
|
| Advisors Management Group | 10k | $2.0k | 0% | Jun 2025 |
|
| Kitzinger Lautmann Capital Management | 10k | $2.4k | 0% | Sep 2025 |
|
| Coston, McIsaac & Partners | 1.0k | $0 | 0% | Sep 2025 |
|
| Hantz Financial Services | 250.00 | $0 | 0% | Sep 2025 |
|